BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22867781)

  • 1. Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.
    Li C; Zeliadt SB; Hall IJ; Smith JL; Ekwueme DU; Moinpour CM; Penson DF; Thompson IM; Keane TE; Ramsey SD
    Value Health; 2012; 15(5):716-23. PubMed ID: 22867781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using willingness to pay to measure family members' preferences in mental health.
    Mulvaney-Day NE
    J Ment Health Policy Econ; 2005 Jun; 8(2):71-81. PubMed ID: 15998979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
    Oh DY; Crawford B; Kim SB; Chung HC; McDonald J; Lee SY; Ko SK; Ro J
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):282-91. PubMed ID: 22898238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
    Carlsson KS; Höjgård S; Lethagen S; Lindgren A; Berntorp E; Lindgren B
    Haemophilia; 2004 Sep; 10(5):527-41. PubMed ID: 15357780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stated and actual altruistic willingness to pay for insecticide-treated nets in Nigeria: validity of open-ended and binary with follow-up questions.
    Onwujekwe O; Uzochukwu B
    Health Econ; 2004 May; 13(5):477-92. PubMed ID: 15127427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of willingness to pay for implantable cardioverter-defibrillator therapy.
    Nowakowska D; Guertin JR; Liu A; Abrahamowicz M; Lelorier J; Lespérance F; Brophy JM; Rinfret S
    Am J Cardiol; 2011 Feb; 107(3):423-7. PubMed ID: 21257009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
    Barron AC; Lee TL; Taylor J; Moore T; Passo MH; Graham TB; Griffin TA; Grom AA; Lovell DJ; Brunner HI
    Arthritis Rheum; 2004 Dec; 51(6):899-908. PubMed ID: 15593249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for lung cancer treatment.
    Lang HC
    Value Health; 2010; 13(6):743-9. PubMed ID: 20561327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the burden of migraine using the willingness to pay model.
    Hamelsky SW; Lipton RB; Stewart WF
    Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for health insurance among rural and poor persons: field evidence from seven micro health insurance units in India.
    Dror DM; Radermacher R; Koren R
    Health Policy; 2007 Jun; 82(1):12-27. PubMed ID: 16971017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay for dentin regeneration in a sample of dentate adults.
    Birch S; Sohn W; Ismail AI; Lepkowski JM; Belli RF
    Community Dent Oral Epidemiol; 2004 Jun; 32(3):210-6. PubMed ID: 15151691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of the absence of random assignment of bids on estimating willingness to pay using a discrete-choice question.
    Takemura S; Ohida T; Sone T; Fukuda T; Takemura Y
    Health Econ; 2005 Feb; 14(2):209-13. PubMed ID: 15386653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.